» Articles » PMID: 16452670

Presynaptic, Activity-dependent Modulation of Cannabinoid Type 1 Receptor-mediated Inhibition of GABA Release

Overview
Journal J Neurosci
Specialty Neurology
Date 2006 Feb 3
PMID 16452670
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Endocannabinoid signaling couples activity-dependent rises in postsynaptic Ca2+ levels to decreased presynaptic GABA release. Here, we present evidence from paired recording experiments that cannabinoid-mediated inhibition of GABA release depends on the firing rates of the presynaptic interneurons. Low-frequency action potentials in post hoc identified cholecystokinin-positive CA1 basket cells elicited IPSCs in the postsynaptic pyramidal cells that, as expected, were fully abolished by the exogenous application of the cannabinoid receptor agonist WIN55,212-2 [R-(+)-(2,3-dihydro-5-methyl-3-[(4-morpholinyl)methyl]pyrol[1,2,3-de]-1,4-benzoxazin-6-yl)(1-naphthalenyl) methanone monomethanesulfonate] at 5 microM. However, the presynaptic basket cells recovered from the cannabinoid agonist-induced inhibition of GABA release when the presynaptic firing rate was increased to > or =20 Hz. Pharmacological experiments showed that the recovered transmission was exclusively dependent on presynaptic N-type Ca2+ channels. Furthermore, the increased presynaptic firing could also overcome even complete depolarization-induced suppression of inhibition, indicating that the magnitude of DSI markedly depends on the activity levels of basket cells. These results reveal a new locus of activity-dependent modulation for endocannabinoid signaling and suggest that endocannabinoid-mediated inhibition of GABA release may differ in distinct behavioral states.

Citing Articles

Presynaptic nanoscale components of retrograde synaptic signaling.

Barti B, Dudok B, Kenesei K, Zoldi M, Miczan V, Balla G Sci Adv. 2024; 10(22):eado0077.

PMID: 38809980 PMC: 11135421. DOI: 10.1126/sciadv.ado0077.


Retrograde endocannabinoid signaling at inhibitory synapses in vivo.

Dudok B, Fan L, Farrell J, Malhotra S, Homidan J, Kim D Science. 2024; 383(6686):967-970.

PMID: 38422134 PMC: 10921710. DOI: 10.1126/science.adk3863.


Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy.

Jahncke J, Miller D, Krush M, Schnell E, Wright K Elife. 2024; 12.

PMID: 38179984 PMC: 10942650. DOI: 10.7554/eLife.87965.


Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems.

Wiesman A, da Silva Castanheira J, Fon E, Baillet S Ann Neurol. 2023; 95(4):802-816.

PMID: 38146745 PMC: 11023768. DOI: 10.1002/ana.26871.


Behavioral and Molecular Responses to Exogenous Cannabinoids During Pentylenetetrazol-Induced Convulsions in Male and Female Rats.

Zirotti Rosenberg A, Mendez-Ruette M, Gorziglia M, Alzerreca B, Cabello J, Kaufmann S Front Mol Neurosci. 2022; 15:868583.

PMID: 36147210 PMC: 9488559. DOI: 10.3389/fnmol.2022.868583.


References
1.
Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi E, Mackie K . Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci. 1999; 19(11):4544-58. PMC: 6782612. View

2.
Brody D, Yue D . Relief of G-protein inhibition of calcium channels and short-term synaptic facilitation in cultured hippocampal neurons. J Neurosci. 2000; 20(3):889-98. PMC: 6774171. View

3.
Wilson R, Nicoll R . Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 2001; 410(6828):588-92. DOI: 10.1038/35069076. View

4.
Kreitzer A, Regehr W . Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron. 2001; 29(3):717-27. DOI: 10.1016/s0896-6273(01)00246-x. View

5.
Maejima T, Kano M . Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron. 2001; 29(3):729-38. DOI: 10.1016/s0896-6273(01)00247-1. View